Home Podcasts The Research Evangelist
The Research Evangelist

The Research Evangelist

Dave Bjork 12 Episodes Jul 17, 2026

Patient advocate and lung cancer survivor Dave Bjork hosts this podcast, exploring the meaning of "evangelist" as bringing good news. He highlights the work of researchers and clinicians in lung cancer care whom he calls "brilliant but not famous." Each episode features their professional achievements as well as personal stories and passions. The show aims to showcase the dedication and humanity of people working in life sciences.

Episodes

Dave Bjork with Dr Tony Mok From The Halls of ASCO 2026
Dave Bjork with Dr Tony Mok From The Halls of ASCO 2026 Jul 17, 2026 484 I sat down with Dr. Tony Mok to tell us what we need to know about the seven year update of the Phase 3 CROWN study for advanced ALK-positive non-small cell lung cancer (NSCLC) presented at ASCO.Send us Fan Mailresearchevangelist.com
Meet Dr. Sarah Goldberg From The Halls of ASCO 2026
Meet Dr. Sarah Goldberg From The Halls of ASCO 2026 Jul 17, 2026 618 I sat down with Dr. Sarah Goldberg to talk about the COPERNICUS Study for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) abstract she presented at ASCO.Send us Fan Mailresearchevangelist.com
Dave Bjork with Dr Melissa Johnson From The Halls of ASCO 2026
Dave Bjork with Dr Melissa Johnson From The Halls of ASCO 2026 Jul 16, 2026 622 I sat down with Dr. Melissa Johnson, one of the authors of the Phase 3 LIBRETTO-432 Trial abstract presented at ASCO.Send us Fan Mailresearchevangelist.com
Meet Dr. Yasir Elamin | From The Halls of ASCO 2026
Meet Dr. Yasir Elamin | From The Halls of ASCO 2026 Jul 9, 2026 636 I sat down with Dr. Yasir Elamin to get his thoughts on his presentation at ASCO regarding patient reported outcomes and health-related quality of life with Taletrectinib in advanced ROS1 non-small cell lung cancer (NSCLC)  from the TRUST-II Study.Send us Fan Mailresearchevangelist.com
Meet Professor Sanjay Popat | From The Halls of ASCO 2026
Meet Professor Sanjay Popat | From The Halls of ASCO 2026 Jul 9, 2026 484 I sat down with Professor Sanjay Popat to get his thoughts on the ROSETTA Lung-02 abstract presented at ASCO and what it could mean for clinical practice, future research, and patient care.Send us Fan Mailresearchevangelist.com
Meet Dr. Nasser H. Hanna | From The Halls of ASCO 2026
Meet Dr. Nasser H. Hanna | From The Halls of ASCO 2026 Jul 7, 2026 931 I sat down with Dr. Nasser H. Hanna to get his thoughts on three lung cancer research abstracts presented at ASCO that he is most excited about, and what they could mean for clinical practice, future research, and patient care.Send us Fan Mailresearchevangelist.com
Meet Dr. Fawzi Abu Rous, a thoracic medical oncologist at Henry Ford Health in Detroit, Michigan…
Meet Dr. Fawzi Abu Rous, a thoracic medical oncologist at Henry Ford Health in Detroit, Michigan… Sep 25, 2025 2189 On today’s episode, meet Dr. Fawzi Abu Rous, a thoracic medical oncologist at Henry Ford Health in Detroit, Michigan. Dr. Abu Rous earned his MD from the University of Jordan Faculty of Medicine in 2015. He completed his residency at Michigan State University and graduated from his Hematology and Oncology Fellowship at Henry Ford Health.Dr. Abu Rous conducts research on lung cancer, specializing i
Meet Dr. Hina Khan, a medical oncologist who specializes in thoracic cancers...
Meet Dr. Hina Khan, a medical oncologist who specializes in thoracic cancers... May 23, 2025 2605  On today's episode meet Dr. Hina Khan. Dr. Khan is a medical oncologist who specializes in thoracic cancers and is an Assistant Professor at the Warren Alpert Medical School at Brown University. She practices at Rhode Island, The Miriam and Newport hospitals and she is board certified in internal medicine, hematology and oncology. Dr. Khan received her medical degree from the Jawaharlal Nehr
Meet Lori Sakoda, a research scientist in the Division of Research at Kaiser Permanente Northern California...
Meet Lori Sakoda, a research scientist in the Division of Research at Kaiser Permanente Northern California... May 1, 2025 2254 On today's episode meet Lori Sakoda. Lori is a research scientist in the Division of Research at Kaiser Permanente Northern California, and Associate Professor of Health Systems Science at the Kaiser Permanente Bernard J. Tyson School Of Medicine. Her research interests currently encompass identifying genetic and environmental determinants of risk in prognoses for cancer, particularly of lung
Meet Dr. Joshua Bauml, the Lung Cancer Disease Area Stronghold Leader at Johnson & Johnson Innovative Medicine...
Meet Dr. Joshua Bauml, the Lung Cancer Disease Area Stronghold Leader at Johnson & Johnson Innovative Medicine... Feb 21, 2025 2229 On today's episode meet Dr. Joshua Bauml. Dr. Bauml is the Lung Cancer Disease Area Stronghold Leader at Johnson & Johnson Innovative Medicine...Send us Fan Mailresearchevangelist.com
Meet Dr. Eric Singhi, the Assistant Professor of both the Department General Oncology Division of Cancer Medicine and the Department of Thoracic Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston
Meet Dr. Eric Singhi, the Assistant Professor of both the Department General Oncology Division of Cancer Medicine and the Department of Thoracic Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston Jan 22, 2025 2381 On today’s episode, meet Dr. Eric Singhi. Dr. Singhi is the Assistant Professor of both the Department General Oncology Division of Cancer Medicine and the Department of Thoracic Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston.He received his medical degree at the Medical University of South Carolina. He completed his clinical residency at Vanderbilt
Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at  Johnson & Johnson...
Meet Biljana Naumovic, President of U.S. Oncology, Solid Tumor at Johnson & Johnson... Dec 10, 2024 2386 On today’s episode, meet Biljana Naumovic. Biljana is the President of U.S. Oncology, Solid Tumor at  Johnson & Johnson, where she is spearheading innovative cancer  treatments and advocating for equity in healthcare.  She is committed to advancing the  organization’s solid tumor portfolio and pipeline, spanning prostate,  bladder, and lung cancer, as well as multiple novel treatment pathways.

Recommended